118 related articles for article (PubMed ID: 1185059)
1. On the immunology of head and neck cancer--a prognostic index. Preliminary communication.
Parker R; Alexander S; Shaheen OH; Parkes P
J Laryngol Otol; 1975 Jul; 89(7):687-95. PubMed ID: 1185059
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
Osoba D; Kersey PA; Clark RM; Rosen IB
Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune response in head and neck cancer patients.
Olivari A; Pradier R; Feierstein J; Guardo A; Glait H; Rojas A
J Surg Oncol; 1976; 8(4):287-94. PubMed ID: 781404
[TBL] [Abstract][Full Text] [Related]
5. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
6. Dinitrochlorobenzene skin sensitization and peripheral lymphocyte count: predictors of survival in head and neck cancer.
Maisel RH; Ogura JH
Ann Otol Rhinol Laryngol; 1976; 85(4 Pt 1):517-22. PubMed ID: 949158
[TBL] [Abstract][Full Text] [Related]
7. Immunobiologic staging of patients with carcinoma of the head and neck.
Katz AE
Laryngoscope; 1983 Apr; 93(4):445-63. PubMed ID: 6339850
[TBL] [Abstract][Full Text] [Related]
8. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
Browder JP; Chretien PB
Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
[No Abstract] [Full Text] [Related]
9. Nutritional status and general immune competence in patients with head and neck cancer.
Brookes GB; Clifford P
J R Soc Med; 1981 Feb; 74(2):132-9. PubMed ID: 7205848
[TBL] [Abstract][Full Text] [Related]
10. T-cell deficiency in patients with squamous cell cancer of the head and neck.
Wanebo HJ; Jun MY; Strong EW; Oettgen H
Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
[TBL] [Abstract][Full Text] [Related]
11. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
12. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
[TBL] [Abstract][Full Text] [Related]
13. Cellular immunity in patients with epidermoid cancer of the head and neck.
Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
[TBL] [Abstract][Full Text] [Related]
14. Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy.
Zighelboim J; Dorey F; Parker NH; Calcaterra T; Ward P; Fahey JL
Cancer; 1979 Jul; 44(1):117-23. PubMed ID: 313240
[TBL] [Abstract][Full Text] [Related]
15. The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region.
Bier J; Nicklisch U; Platz H
Cancer; 1983 Oct; 52(7):1165-72. PubMed ID: 6603897
[TBL] [Abstract][Full Text] [Related]
16. Immunological status of patients in carcinoma head and neck.
Vasenwala SM; Aziz M; Rattan A; Ahmad KN
Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
[TBL] [Abstract][Full Text] [Related]
17. Delayed hypersensitivity to DNCB and survival following radiation therapy in patients with solid malignant tumors.
Hazra TA; Parks LC; Inalsingh A; Peeples W
Radiology; 1975 May; 115(2):429-30. PubMed ID: 1144761
[TBL] [Abstract][Full Text] [Related]
18. [The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes].
Bianucci P; Pastorino G; Brondi P
Minerva Med; 1982 Oct; 73(41):2891-5. PubMed ID: 7133502
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune profile and T-lymphocyte blocking factors in cancer of the head and neck and their prognostic significance.
Sinha R; Gupta SC; Naithani YP
Indian J Cancer; 1985 Mar; 22(1):8-16. PubMed ID: 3879757
[No Abstract] [Full Text] [Related]
20. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
Stefano S; Kerman R; Abbate J
AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
